文献速递治疗药物监测与药物基因组学

机器学习支持基于药代动力学数据个体化给药方案的方法学技术:范围综述

Methodological Techniques Used in Machine Learning to Support Individualized Drug Dosing Regimens Based on Pharmacokinetic Data: A Scoping Review.
PubMed 文献 · Clin Pharmacokinet · 2025-08-14

结果显示 boosting、树基、实例基和回归基模型最常用,约31%研究将机器学习与群体药代动力学模型整合;机器学习模型预测准确性相当或优于群体药代动力学模型,尤其在药代动力学变异性大的药物中。

要点

  • 机器学习模型在个体化给药预测中准确性可比或优于群体药代动力学模型。
  • 仅60%研究报告特征选择方法,47%使用内部测试集,方法学异质性大。
  • 约31%研究将机器学习与群体药代动力学模型整合,其余为独立模型。

核心结论

  • 机器学习建模方法、特征选择和模型评估存在显著异质性,需标准化报告和方法学实践以提升可重复性和临床适用性。

主要发现

  • boosting基、树基、实例基和回归基模型是最常用的机器学习方法。
  • 约31%的研究将机器学习与群体药代动力学模型整合,其余开发独立机器学习模型。
  • 仅60%的研究详细报告特征选择方法。
  • 47%的机器学习模型使用内部测试集,其余采用外部数据集或混合方法。
  • 机器学习模型预测准确性相当或优于群体药代动力学模型,尤其对药代动力学变异性显著的药物。

局限性

  • 纳入研究在机器学习建模方法、特征选择和模型评估方面存在显著异质性,仅60%报告特征选择方法,47%使用内部测试集。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: Individualized drug dosing is a highly effective strategy for optimizing therapeutic outcomes, especially for drugs with high inter-individual variability. Population pharmacokinetic modeling is a widely used approach to characterize inter-individual variability in therapeutic drug monitoring. However, the development of population pharmacokinetic models is labor intensive and requires significant technical expertise. Machine learning (ML) represents a promising alternative for personalized drug dosing strategies. Despite numerous studies applying ML in this context, no previous work has comprehensively reviewed and compared their methodologies and predictive performance. This scoping review addresses this gap in the existing literature with the aim to examine the methodological approaches used in ML-based pharmacokinetic modeling for dose optimization. METHODS: Five databases were systematically searched from their inception to May 2025. Studies comparing predictions of drug concentrations or pharmacokinetic parameters between ML and population pharmacokinetic models were included. Studies published in non-English language, reviews, protocols, or studies that did not employ ML models for individualized dose regimens or treatment plans were excluded. RESULTS: Fifty-eight studies were included. We found that boosting-based models, tree-based models, instance-based, and regression-based models were the most commonly used ML approaches. Approximately 31% of the studies integrated ML with population pharmacokinetic models, while the remainder developed stand-alone ML models. Inconsistencies in reporting were evident, as only 60% of the studies detailed their feature selection methods. Model evaluation approaches also varied: 47% of ML models used internal test sets, while the remainder employed external datasets or mixed approaches. In terms of predictive accuracy, ML models performed comparably to or better than population pharmacokinetic models, especially for drugs with significant pharmacokinetic variability. CONCLUSIONS: This review identifies substantial heterogeneity in ML modeling approaches, feature selection, and model evaluation. To enhance the reproducibility and clinical applicability of ML models in individualized drug dosing, standardization in reporting and methodological practices is essential.

来源:Clin Pharmacokinet,查看原文。版权归原作者所有。

引用

  1. Methaneethorn J, Duangchaemkarn K, Reisfeld B, et al. Methodological Techniques Used in Machine Learning to Support Individualized Drug Dosing Regimens Based on Pharmacokinetic Data: A Scoping Review. Clin Pharmacokinet. 2025. PMID: 40810920. doi:10.1007/s40262-025-01547-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。